Nitrous oxide

Description

Nitrous Oxide USP is a colorless, non-flammable gas with a slightly sweet odor and taste. Its chemical name is nitrous oxide, and it has a CAS number of 10024-97-2.

Uses and Indications

Nitrous Oxide is indicated for use in medical settings under the supervision of a licensed practitioner who is experienced in its administration. This drug is utilized for its anesthetic properties, providing analgesia and sedation during various medical procedures.

There are no specific teratogenic or nonteratogenic effects associated with Nitrous Oxide as per the available data.

Dosage and Administration

Administration of Nitrous Oxide is to be conducted exclusively by or under the supervision of a licensed practitioner experienced in its use and administration, as it may pose hazards or be contraindicated in certain situations.

The route of administration is via respiratory inhalation. The active ingredient is Nitrous Oxide, supplied at a concentration of 990 mL in a 1 L cylinder. It is imperative to utilize equipment that is rated for cylinder pressure to ensure safety during administration.

Prior to use, the valve should be opened slowly to prevent sudden pressure release. A backflow preventive device must be employed in the piping to avoid any potential hazards. After each use, and when the cylinder is empty, the valve should be securely closed. It is critical not to open the valve until it is connected to the appropriate equipment that is prepared for use.

Contraindications

Administration of Nitrous Oxide is contraindicated in the following situations:

• Handling of Nitrous Oxide should only occur after all safety precautions have been thoroughly read and understood.

• Inhalation of the gas is contraindicated; avoid breathing in Nitrous Oxide.

• Contact with eyes, skin, or clothing must be avoided to prevent potential harm.

• Use and storage of Nitrous Oxide should be limited to outdoor settings or well-ventilated areas to mitigate risks associated with gas accumulation.

• The valve should not be opened until it is securely connected to equipment that is prepared for use to prevent accidental release.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazards and Risks Nitrous Oxide is classified as an oxidizer and may cause or intensify fire; therefore, it must be handled with extreme caution. The gas is stored under pressure and poses an explosion risk if subjected to heat. Users should be aware that exposure may lead to drowsiness or dizziness, and the gas can displace oxygen, resulting in rapid suffocation. Additionally, contact with the gas may cause frostbite.

General Precautions Prior to handling Nitrous Oxide, all safety precautions must be thoroughly read and understood. It is essential to store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Users should avoid inhaling the gas and prevent contact with eyes, skin, or clothing. Nitrous Oxide should only be used and stored outdoors or in well-ventilated areas. Protective gloves, clothing, and either eye or face protection are recommended during use.

In the event of a fire, efforts should be made to stop the leak if it is safe to do so. The gas must be stored securely and locked up when not in use. Disposal of the contents or container should follow the instructions provided by the supplier or owner. Users should protect the gas from sunlight when ambient temperatures exceed 52°C (125°F) and utilize a backflow preventive device in the piping. Valves should be closed after each use and when the cylinder is empty. Equipment used must be rated for cylinder pressure, compatible with the materials of construction, and cleaned for oxygen service. Valves should be opened slowly, and they should not be opened until connected to the appropriate equipment. It is crucial to read and follow the Safety Data Sheet (SDS) prior to use.

Emergency Instructions In case of feeling unwell, it is advised to contact a poison center or a physician immediately. If Nitrous Oxide comes into contact with the skin, affected areas should be thawed with lukewarm water without rubbing, and immediate medical advice or attention should be sought.

Side Effects

The administration of Nitrous Oxide is associated with several adverse reactions that warrant careful consideration. Serious warnings include the potential to cause or intensify fire, as it is classified as an oxidizer. Additionally, Nitrous Oxide may cause drowsiness or dizziness, which can impact a patient's ability to perform tasks that require full cognitive function. There is also a risk of oxygen displacement, which can lead to rapid suffocation, and exposure to the gas may result in frostbite.

Due to these risks, the use of Nitrous Oxide may be hazardous or contraindicated in certain situations. It is imperative that Nitrous Oxide is administered only by or under the supervision of a licensed practitioner who possesses experience in its use. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, and side effects, along with the necessary precautions to ensure patient safety.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients have not been specifically addressed regarding the use of Nitrous Oxide. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for children provided in the available information. Therefore, healthcare professionals should exercise caution and consider the lack of pediatric-specific data when contemplating the use of Nitrous Oxide in this population.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Administration of Nitrous Oxide may pose hazards or be contraindicated during pregnancy. While specific risks to the fetus are not detailed in the available data, caution is strongly advised when considering its use in pregnant patients. It is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who has experience in its administration, particularly in this population. Healthcare professionals should carefully weigh the potential risks and benefits before administering Nitrous Oxide to pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there is no information available about the potential for excretion of Nitrous Oxide in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential risks associated with excessive administration of the medication.

In the event of suspected overdosage, it is recommended that healthcare providers assess the patient's clinical status and consider the following general management procedures:

1. Assessment of Symptoms: Healthcare professionals should monitor for any unusual or severe symptoms that may arise, which could indicate an adverse reaction to the medication. Symptoms may vary depending on the drug class and individual patient factors.

2. Supportive Care: Supportive measures should be initiated as necessary. This may include maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

3. Contact Poison Control: In cases of suspected overdose, it is advisable to contact a poison control center for guidance on specific management strategies tailored to the medication involved.

4. Consideration of Antidotes: If applicable, healthcare providers should be aware of any available antidotes or specific treatments that may mitigate the effects of the overdose.

5. Documentation and Reporting: All instances of overdosage should be thoroughly documented in the patient's medical record, and adverse events should be reported to the appropriate regulatory authorities as per local guidelines.

Healthcare professionals are encouraged to consult the product's prescribing information for any additional details regarding overdosage management specific to the medication in question.

Nonclinical Toxicology

No teratogenic effects were reported in animal studies. Additionally, adverse developmental outcomes were not observed in these studies. Animal studies did not demonstrate any significant toxic effects related to nitrous oxide exposure. No specific nonclinical toxicology data were provided.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of the product. These include hypoxia, neurological effects, nausea and vomiting, dizziness, headache, and an increased risk of accidents due to impaired judgment and coordination. Additionally, there is a potential for abuse and dependence.

Further safety information derived from postmarketing data indicates reports of misuse and abuse across various populations, including healthcare professionals. Serious adverse events, including fatalities, have been associated with the use of nitrous oxide. It is recommended that patients be monitored for signs of hypoxia and other adverse effects during and after administration.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards and is contraindicated in certain situations. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide, including its ability to cause or intensify fire, as it is classified as an oxidizer. They should be cautioned that the gas is under pressure and may explode if heated. Additionally, patients should be informed that Nitrous Oxide may cause drowsiness or dizziness, and it can displace oxygen, leading to rapid suffocation. Frostbite is also a risk if the gas comes into contact with skin.

It is crucial for patients to understand the importance of reading and comprehending all safety precautions before handling Nitrous Oxide. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing the gas and should take care to prevent contact with eyes, skin, or clothing.

Healthcare providers should emphasize the necessity of using and storing Nitrous Oxide only outdoors or in well-ventilated areas. Patients should be advised to wear protective gloves, clothing, and either eye or face protection when handling the gas. In the event of a fire, patients should be instructed to stop the leak if it is safe to do so.

Patients should be informed that Nitrous Oxide should be stored securely and locked up when not in use. They should be made aware of the proper disposal methods for the contents and container, in accordance with the supplier's instructions. Additionally, patients should be cautioned to protect the gas from sunlight when the ambient temperature exceeds 52°C (125°F).

Healthcare providers should instruct patients to use a backflow preventive device in the piping and to close the valve after each use and when the cylinder is empty. They should only open the valve when connected to equipment prepared for use and ensure that the equipment is rated for cylinder pressure and made of compatible materials. Patients should be advised to open the valve slowly and to use only equipment that has been cleaned for oxygen service.

Before use, patients should read and follow the Safety Data Sheet (SDS). In case of an emergency, healthcare providers should inform patients of the first aid measures: if inhaled, they should be removed to fresh air and kept comfortable for breathing, and a poison center or physician should be contacted if they feel unwell. If Nitrous Oxide comes into contact with skin, patients should thaw the affected area with lukewarm water without rubbing it and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in a secure manner and must be stored in a locked location. It is essential to protect the product from sunlight when the ambient temperature exceeds 52°C (125°F). The storage area should be free from clothing and other combustible materials to ensure safety.

Valves and fittings must be kept free from grease and oil to maintain integrity. The product should only be used and stored outdoors or in a well-ventilated area. After each use and when the product is empty, the valve should be closed to prevent any accidental release.

It is crucial to use the product only with equipment that is rated for cylinder pressure. The valve should not be opened until it is connected to equipment that is prepared for use, and it should be opened slowly to avoid any sudden release of pressure. Additionally, the product must only be used with equipment that has been cleaned for oxygen service.

Finally, disposal of the contents and container should be conducted in accordance with the instructions provided by the container supplier or owner.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by AGP LLC. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)